ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,586 Cr | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr |
What is the latest Total Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹8,586 Cr |
| Mar2025 | ₹7,709 Cr |
| Mar2024 | ₹6,341 Cr |
| Mar2023 | ₹6,064 Cr |
| Mar2022 | ₹7,230 Cr |
How is Total Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,586 Cr | 11.38 | |
| Mar2025 | ₹7,709 Cr | 21.57 | |
| Mar2024 | ₹6,341 Cr | 4.58 | |
| Mar2023 | ₹6,064 Cr | -16.13 | |
| Mar2022 | ₹7,230 Cr | - | |
Compare Total Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,156.9 Cr | -2.2% | -9.3% | -17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -2.2% |
-9.3% |
-17.5% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses